Lv3
330 积分 2023-11-02 加入
JAKing up immunity
1天前
已完结
Cytokines in cancer
1天前
已完结
Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer
12天前
已完结
Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data
12天前
已完结
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
12天前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
16天前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
17天前
已完结
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
21天前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
22天前
已完结
Non-small-cell lung cancer
24天前
已完结
皖公网安备34019202002308
